These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26401941)

  • 21. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months.
    Thai C; Lim YY; Villemagne VL; Laws SM; Ames D; Ellis KA; Rainey-Smith SR; Martins RN; Masters CL; Rowe CC; Maruff P;
    PLoS One; 2015; 10(10):e0139082. PubMed ID: 26430784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOE e4 genotype and cigarette smoking in adults with normal cognition and mild cognitive impairment: a retrospective baseline analysis of a national dataset.
    Kalapatapu RK; Delucchi KL
    Am J Drug Alcohol Abuse; 2013 Jul; 39(4):219-26. PubMed ID: 23808899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signature.
    Alexopoulos P; Guo LH; Jiang M; Bujo H; Grimmer T; Förster S; Drzezga A; Kurz A; Perneczky R
    J Alzheimers Dis; 2013; 36(2):401-8. PubMed ID: 23609762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the apolipoprotein e genotype a biomarker for mild cognitive impairment? Findings from a nationally representative study.
    Brainerd CJ; Reyna VF; Petersen RC; Smith GE; Taub ES
    Neuropsychology; 2011 Nov; 25(6):679-89. PubMed ID: 21728427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing.
    Brown BM; Peiffer JJ; Taddei K; Lui JK; Laws SM; Gupta VB; Taddei T; Ward VK; Rodrigues MA; Burnham S; Rainey-Smith SR; Villemagne VL; Bush A; Ellis KA; Masters CL; Ames D; Macaulay SL; Szoeke C; Rowe CC; Martins RN
    Mol Psychiatry; 2013 Aug; 18(8):875-81. PubMed ID: 22889922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition.
    Wierenga CE; Dev SI; Shin DD; Clark LR; Bangen KJ; Jak AJ; Rissman RA; Liu TT; Salmon DP; Bondi MW
    J Cereb Blood Flow Metab; 2012 Aug; 32(8):1589-99. PubMed ID: 22549621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aβ amyloid, cognition, and APOE genotype in healthy older adults.
    Lim YY; Ellis KA; Ames D; Darby D; Harrington K; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Villemagne VL; Maruff P;
    Alzheimers Dement; 2013 Sep; 9(5):538-45. PubMed ID: 23159043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden.
    Rembach A; Watt AD; Wilson WJ; Villemagne VL; Burnham SC; Ellis KA; Maruff P; Ames D; Rowe CC; Macaulay SL; Bush AI; Martins RN; Masters CL; Doecke JD;
    J Alzheimers Dis; 2014; 40(1):95-104. PubMed ID: 24334723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints.
    Mosconi L; De Santi S; Brys M; Tsui WH; Pirraglia E; Glodzik-Sobanska L; Rich KE; Switalski R; Mehta PD; Pratico D; Zinkowski R; Blennow K; de Leon MJ
    Biol Psychiatry; 2008 Mar; 63(6):609-18. PubMed ID: 17720148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APOE Genotype Influences Postprandial Blood Pressure after High Fat Feeding in Older Adults.
    Stewart KC; Subramanian D; Neal UJ; Hanson AJ
    J Nutr Health Aging; 2019; 23(5):408-413. PubMed ID: 31021357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a straightforward and sensitive scale for MCI and early AD clinical trials.
    Huang Y; Ito K; Billing CB; Anziano RJ;
    Alzheimers Dement; 2015 Apr; 11(4):404-14. PubMed ID: 25022537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
    van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
    J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between cognitive performance and insulin resistance in non-diabetic patients with mild cognitive impairment.
    Kim TE; Lee DH; Kim YJ; Mok JO; Kim CH; Park JH; Lee TK; Yoo K; Jeong Y; Lee Y; Park SA
    Int J Geriatr Psychiatry; 2015 Jun; 30(6):551-7. PubMed ID: 25060738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary fat manipulation has a greater impact on postprandial lipid metabolism than the apolipoprotein E (epsilon) genotype-insights from the SATgenε study.
    Jackson KG; Lockyer S; Carvalho-Wells AL; Williams CM; Minihane AM; Lovegrove JA
    Mol Nutr Food Res; 2012 Dec; 56(12):1761-70. PubMed ID: 23097177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher Blood Vitamin C Levels are Associated with Reduction of Apolipoprotein E E4-related Risks of Cognitive Decline in Women: The Nakajima Study.
    Noguchi-Shinohara M; Abe C; Yuki-Nozaki S; Dohmoto C; Mori A; Hayashi K; Shibata S; Ikeda Y; Sakai K; Iwasa K; Yokogawa M; Ishimiya M; Nakamura H; Yokoji H; Komai K; Nakamura H; Yamada M
    J Alzheimers Dis; 2018; 63(4):1289-1297. PubMed ID: 29758939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between apolipoprotein E4 and cognitive decline in elderly adults.
    Packard CJ; Westendorp RG; Stott DJ; Caslake MJ; Murray HM; Shepherd J; Blauw GJ; Murphy MB; Bollen EL; Buckley BM; Cobbe SM; Ford I; Gaw A; Hyland M; Jukema JW; Kamper AM; Macfarlane PW; Jolles J; Perry IJ; Sweeney BJ; Twomey C;
    J Am Geriatr Soc; 2007 Nov; 55(11):1777-85. PubMed ID: 17979899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APOE-Genotype and Insulin Modulate Estimated Effect of Dietary Macronutrients on Cognitive Performance: Panel Analyses in Nondiabetic Older Adults at Risk of Dementia.
    Norgren J; Sindi S; Matton A; Kivipelto M; Kåreholt I
    J Nutr; 2023 Dec; 153(12):3506-3520. PubMed ID: 37778510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.